Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695863 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep
A Phase 4 study of Colorectal Cancer, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT01695863 is a Phase 4 study of Colorectal Cancer that has completed, run by Rush University Medical Center. The registered enrollment target is 150 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01695863, a Phase 4 study of Colorectal Cancer, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.
Conditions Studied
Interventions
- DRUG comparing 2 drugs on their effect on the bowel preparation for colonoscopy
Study Locations (1)
Illinois
- Rush Unversity Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01695863
The ClinicalTrials.gov registry entry for NCT01695863 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which comparing 2 drugs on their effect on the bowel preparation for colonoscopy is the first listed.
NCT01695863 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01695863 about?
NCT01695863 is a clinical study titled "Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep". This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.
What is the current status of trial NCT01695863?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2012-02. Estimated completion is 2014-01.
What conditions does trial NCT01695863 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT01695863?
The interventions under investigation include: comparing 2 drugs on their effect on the bowel preparation for colonoscopy (DRUG).
Who is sponsoring clinical trial NCT01695863?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01695863 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
RECRUITING · Phase 4
-
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
COMPLETED · Phase 4
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.